Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Twist Bioscience Corporation (TWST) Debt to Capital Ratio data is not available for the most recently reported fiscal year, ending 2023-09-30.
| Income Statement Financials | |
$245.11M |
|
$-204.62M |
|
$155.38M |
|
$89.73M |
|
$462.27M |
|
$-217.16M |
|
$13.69M |
|
$-203.47M |
|
$-203.47M |
|
$-204.62M |
|
$-204.62M |
|
$-204.62M |
|
$-204.62M |
|
$-217.16M |
|
$-187.85M |
|
56.88M |
|
56.88M |
|
$-3.60 |
|
$-3.60 |
|
| Balance Sheet Financials | |
$424.26M |
|
$131.83M |
|
$352.15M |
|
$776.40M |
|
$73.32M |
|
-- |
|
$79.65M |
|
$152.97M |
|
$623.43M |
|
$483.14M |
|
$623.43M |
|
57.56M |
|
| Cash Flow Statement Financials | |
$-142.47M |
|
$50.61M |
|
$0.91M |
|
$380.26M |
|
$289.28M |
|
$-90.98M |
|
$30.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.79 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
36.61% |
|
-88.60% |
|
-88.60% |
|
-76.64% |
|
-83.01% |
|
-83.48% |
|
$-170.25M |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
4.85 |
|
5.56 |
|
65.62 |
|
-32.82% |
|
-42.35% |
|
-26.35% |
|
-32.82% |
|
$10.83 |
|
$-2.99 |
|
$-2.50 |
|